← FDA Drug Approvals (Drugs@FDA)
DIVALPROEX SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2020-11-17
Drug application
- FDA Application #
ANDA211505- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DIVALPROEX SODIUM
- Generic name
- Divalproex Sodium
- Active ingredients
- DIVALPROEX SODIUM
- Dosage form
- CAPSULE, DELAYED REL PELLETS
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TEVA PHARMS USA
- First approval
- 2020-11-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown